Fairvalue-Calculator Fairvalue-Calculator
EN DE

NIOX Group (NIOX) Fair Value & Analysis

Healthcare · GB · Market cap 248M GBX

Pricep0.5800
Fair Valuep0.3800
Upside-34.5%
Quality83/100
Evidence: Medium Range p0.2800 – p0.4700

Fair value as of: Jun 24, 2026

Analysis

NIOX Group (NIOX) currently trades at p0.5800, while our model-based Fair Value estimate is p0.3800 — implying the stock looks roughly 34.5% overvalued today. We read business quality at 83/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -9% Boston Scientific Corporation (B1SX34) -83% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is NIOX Group (NIOX) undervalued?
As of Jun 24, 2026, our model estimates a fair value of p0.3800 versus a price of p0.5800 — about −34% (overvalued). Model-based estimate, not financial advice.
What is the fair value of NIOX?
Our 21-model fair value for NIOX Group is p0.3800 (as of Jun 24, 2026), built from audited fundamentals. The current price is p0.5800.
What is the quality score of NIOX?
NIOX Group has a Quality Score of 83/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.